Showing 1 – 3 of 3
Relevance | Newest | Oldest |
  • JAMA Original Investigation
    April 24, 2024

    Neurodevelopmental Outcomes After Late Preterm Antenatal Corticosteroids: The ALPS Follow-Up Study

    Cynthia聽Gyamfi-Bannerman,聽MD, MS; Rebecca G.听Clifton,聽PhD; Alan T. N.听Tita,聽MD, PhD; Sean C.听Blackwell,聽MD; Monica聽Longo,聽MD, PhD; Jessica A.听de Voest,聽PhD; T. Michael聽O鈥橲hea,聽MD, MPH; Sabine Z.听Bousleiman,聽MSN, MSPH; Felecia聽Ortiz,聽RN, BSN; Dwight J.听Rouse,聽MD; Torri D.听Metz,聽MD, MS; George R.听Saade,聽MD; Kara M.听Rood,聽MD; Kent D.听Heyborne,聽MD; John M.听Thorp聽Jr,聽MD; Geeta K.听Swamy,聽MD; William A.听Grobman,聽MD, MBA; Kelly S.听Gibson,聽MD; Yasser Y.听El-Sayed,聽MD; George A.听Macones,聽MD, MSCE; Eunice Kennedy Shriver Maternal-Fetal Medicine Units Network
    Abstract Full Text
    is active quiz online first
    JAMA. 2024; 10.1001/jama.2024.4303

    This prospective follow-up study of a randomized clinical trial evaluates whether antenatal corticosteroids administered to birthing parents at risk of late preterm delivery were associated with adverse neurodevelopmental effects on their offspring.

  • JAMA Original Investigation
    July 25, 2023

    Cervical Pessary for Prevention of Preterm Birth in Individuals With a Short Cervix: The TOPS Randomized Clinical Trial

    Matthew K.听Hoffman,聽MD, MPH; Rebecca G.听Clifton,聽PhD; Joseph R.听Biggio,聽MD, MS; George R.听Saade,聽MD; Lynda G.听Ugwu,聽PhD; Monica聽Longo,聽MD, PhD; Sabine Z.听Bousleiman,聽MSN, MSPH; Kelly聽Clark,聽BSN, RN; William A.听Grobman,聽MD, MBA; Heather A.听Frey,聽MD; Suneet P.听Chauhan,聽MD; Lorraine聽Dugoff,聽MD; Tracy A.听Manuck,聽MD; Edward K.听Chien,聽MD; Dwight J.听Rouse,聽MD; Hyagriv N.听Simhan,聽MD; M. Sean聽Esplin,聽MD; George A.听Macones,聽MD, MSCE; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (MFMU) Network
    Abstract Full Text
    free access
    JAMA. 2023; 330(4):340-348. 10.1001/jama.2023.10812

    This randomized clinical trial assesses the effect of cervical pessary placement on preterm birth and fetal mortality among pregnant individuals with a cervical length of 20 mm or less.

  • JAMA Original Investigation
    February 7, 2022

    Association of SARS-CoV-2 Infection With Serious Maternal Morbidity and Mortality From Obstetric Complications

    Torri D.听Metz,聽MD, MS; Rebecca G.听Clifton,聽PhD; Brenna L.听Hughes,聽MD, MS; Grecio J.听Sandoval,聽PhD; William A.听Grobman,聽MD, MBA; George R.听Saade,聽MD; Tracy A.听Manuck,聽MD, MS; Monica聽Longo,聽MD, PhD; Amber聽Sowles,聽BSN, RN; Kelly聽Clark,聽BSN, RN; Hyagriv N.听Simhan,聽MD; Dwight J.听Rouse,聽MD; Hector聽Mendez-Figueroa,聽MD; Cynthia聽Gyamfi-Bannerman,聽MD, MS; Jennifer L.听Bailit,聽MD, MPH; Maged M.听Costantine,聽MD; Harish M.听Sehdev,聽MD; Alan T. N.听Tita,聽MD, PhD; George A.听Macones,聽MD; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (MFMU) Network
    Abstract Full Text
    free access is active quiz has multimedia
    JAMA. 2022; 327(8):748-759. 10.1001/jama.2022.1190

    This cohort study evaluates the association of SARS-CoV-2 infection with serious maternal morbidity or mortality related to hypertensive disorders of pregnancy, postpartum hemorrhage, or infection other than SARS-CoV-2.